Web Stats Provided By Google Analytics

Showing posts with label Gilead Sciences. Show all posts
Showing posts with label Gilead Sciences. Show all posts

Monday, July 29, 2013

Gilead Sciences, Inc. (GILD), Celgene Corporation (CELG): Have You Considered Biotech Yet?

We are in the midst of the earnings season, my favorite time of the year. Some of the largest and most powerful publicly traded firms have already reported their second-quarter earnings with a few still left to report.

http://www.insidermonkey.com/blog/gilead-sciences-inc-gild-celgene-corporation-celg-have-you-considered-biotech-yet-209247/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+InsiderMonkey+%28Insider+Monkey%29

Thursday, July 25, 2013

Gilead Sciences, Inc. (GILD) CEO Discusses Q2 2013 Results - Earnings Call Transcript

Ladies and gentlemen, thank you for standing by and welcome to the Gilead Sciences Second Quarter 2013 Earnings Conference Call.

http://seekingalpha.com/article/1574602-gilead-sciences-inc-gild-ceo-discusses-q2-2013-results-earnings-call-transcript?source=feed

Thursday, June 13, 2013

Gilead Sciences, Inc.'s Viread Reduces HIV Risk for Drug Users in Study

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Gilead Sciences Inc. 's Viread pill reduced the risk of injected-drug users contracting the AIDS virus by half in a study in Thailand, a finding that may give public health officials a new weapon to fight HIV's spread.

http://www.biospace.com/news_story.aspx?StoryID=299907&full=1